VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$10.35
−0.48%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -56.6%
- EBITDA
- —
- EPS
- +78.4%
Three-year CAGR
- Revenue
- -96.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- -61.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026